Skip to main content

Advertisement

Log in

Helpfulness of the liver disease scores in cardiac surgery for cirrhotic patients

  • Original Article
  • Published:
General Thoracic and Cardiovascular Surgery Aims and scope Submit manuscript

Abstract

Objectives

Liver cirrhosis is a well-known risk factor of mortality after cardiac surgery, but not considered in the widely used EuroSCOREII (ESII). The objective was to analyse the performance of the ESII, the Child–Pugh–Turcotte (CPT) and the Model of End-stage Liver Disease (MELD) scores to predict hospital mortality in cardiac surgery for cirrhotic patients and to analyse the survival according to the preoperative cirrhosis status.

Methods

Preoperative and cirrhosis characteristics and postoperative outcomes were compared according to hospital mortality. The performance of the 3 scores was analysed by the area under the receiver-operating characteristics (AUC-ROC) by DeLong’s method. The survival of the patients who were discharged was analysed by Kaplan–Meier curves according to the preoperative cirrhosis status.

Results

Seventy-four patients were included. Observed hospital mortality was 12%, the predictive mortality by ESII was 3.9% ± 5.2%, and AUC-ROC was 0.67 [0.44–0.90]. Only the MELD score was discriminant (AUC-ROC 0.75 [0.57–0.93]). The observed hospital mortality increased by threefold over the ESII (12% versus 3.9%, p < 0.001), except the patients with MELD < 10 for whom hospital mortality was similar as ESII (3% versus 2.6%, p = 0.89). Long-term survival was higher for the MELD < 10 patients.

Conclusions

The ESII did not predict hospital mortality after a cardiac surgery in cirrhotic patients and the MELD score should be considered for decision of cardiac intervention in cirrhotic patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Dimarakis I, Grant S, Corless R, Velissaris T, Prince M, Bridgewater B, et al. Impact of hepatic cirrhosis on outcome in adult cardiac surgery. Thorac Cardiovasc Surg. 2015;63:58–66.

    PubMed  Google Scholar 

  2. Garatti A, Daprati A, Cottini M, Russo CF, Tomba MD, Troise G, et al. Cardiac Surgery In Patients With Liver Cirrhosis (CASTER) study: early and long-term outcomes. Ann Thorac Surg. 2020;111(4):1242–51.

    Article  Google Scholar 

  3. Schuppan D, Afdhal NH. Liver cirrhosis. Lancet. 2008;371:838–51.

    Article  CAS  Google Scholar 

  4. Omar RZ, Ambler G, Royston P, Eliahoo J, Taylor KM. Cardiac surgery risk modeling for mortality: a review of current practice and suggestions for improvement. Ann Thorac Surg. 2004;77:2232–7.

    Article  Google Scholar 

  5. Nashef SAM, Roques F, Sharples LD, Nilsson J, Smith C, Goldstone AR, Ulf LU. EuroSCORE II. Eur J Cardiothorac Surg. 2012;41:734–45.

    Article  Google Scholar 

  6. Barili F, Pacini D, Capo A, Rasovic O, Grossi C, Alamanni F, et al. Does EuroSCORE II perform better than its original versions? A multicentre validation study. Eur Heart J. 2013;34:22–9.

    Article  Google Scholar 

  7. Shih T, Paone G, Theurer PF, McDonald D, Shahian DM, Prager RL. The society of thoracic surgeons adult cardiac surgery database version 2.73: more is better. Ann Thorac Surg. 2015;100:516–21.

    Article  Google Scholar 

  8. Chou H-W, Lin M-H, Chen Y-S, Yu H-Y. Impact of MELD score and cardiopulmonary bypass duration on post-operative hypoxic hepatitis in patients with liver cirrhosis undergoing open heart surgery. J Formos Med Assoc Taiwan Yi Zhi. 2020;119:838–44.

    Article  Google Scholar 

  9. Jacob KA, Hjortnaes J, Kranenburg G, de Heer F, Kluin J. Mortality after cardiac surgery in patients with liver cirrhosis classified by the Child–Pugh score. Interact Cardiovasc Thorac Surg. 2015;20:520–30.

    Article  Google Scholar 

  10. Kamath PS, Kim WR. Advanced liver disease study group the model for end-stage liver disease (MELD). Hepatology. 2007;45:797–805.

    Article  Google Scholar 

  11. Takkenberg JJM, Kappetein AP, Steyerberg EW. Editorial Comment: The role of EuroSCORE II in 21st century cardiac surgery practice. Eur J Cardiothorac Surg. 2013;43:32–3.

    Article  Google Scholar 

  12. Vanhuyse F, Maureira P, Portocarrero E, Laurent N, Lekehal M, Carteaux J-P, et al. Cardiac surgery in cirrhotic patients: results and evaluation of risk factors. Eur J Cardio-Thorac Surg Off J Eur Assoc Cardio-Thorac Surg. 2012;42:293–9.

    Article  Google Scholar 

  13. Child CG, Turcotte JG. Surgery and portal hypertension. Major Probl Clin Surg. 1964;1:1–85.

    CAS  PubMed  Google Scholar 

  14. Suman A, Barnes DS, Zein NN, Levinthal GN, Connor JT, Carey WD. Predicting outcome after cardiac surgery in patients with cirrhosis: a comparison of Child–Pugh and MELD scores. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2004;2:719–23.

    Google Scholar 

  15. Filsoufi F, Salzberg SP, Rahmanian PB, Schiano TD, Elsiesy H, Squire A, et al. Early and late outcome of cardiac surgery in patients with liver cirrhosis. Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc. 2007;13:990–5.

    Google Scholar 

  16. Thielmann M, Mechmet A, Neuhäuser M, Wendt D, Tossios P, Canbay A, et al. Risk prediction and outcomes in patients with liver cirrhosis undergoing open-heart surgery. Eur J Cardio-Thorac Surg Off J Eur Assoc Cardio-Thorac Surg. 2010;38:592–9.

    Article  Google Scholar 

  17. Habibzadeh F, Habibzadeh P, Yadollahie M. On determining the most appropriate test cut-off value: the case of tests with continuous results. Biochem Medica. 2016;26:297–307.

    Article  Google Scholar 

  18. Chou A-H, Chen T-H, Chen C-Y, Chen S-W, Lee C-W, Liao C-H, et al. Long-term outcome of cardiac surgery in 1,040 liver cirrhosis patient—nationwide population-based cohort study—. Circ J. 2017;81:476–84.

    Article  Google Scholar 

  19. Chen Y, Liu YX, Seto WK, Wu MZ, Yu YJ, Lam YM, et al. Prognostic value of hepatorenal function by modified model for end-stage liver disease (MELD) score in patients undergoing tricuspid annuloplasty. J Am Heart Assoc. 2018;7:e009020.

    Article  CAS  Google Scholar 

  20. Lin C-H, Hsu R-B. Cardiac surgery in patients with liver cirrhosis: risk factors for predicting mortality. World J Gastroenterol WJG. 2014;20:12608–14.

    Article  Google Scholar 

  21. Sharma P, Ananthanarayanan C, Vaidhya N, Malhotra A, Shah K, Sharma R. Hyperbilirubinemia after cardiac surgery: an observational study. Asian Cardiovasc Thorac Ann. 2015;23:1039–43.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alexandre Sebestyen.

Ethics declarations

Conflict of interest

All authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sebestyen, A., Boutayeb, A., Durand, M. et al. Helpfulness of the liver disease scores in cardiac surgery for cirrhotic patients. Gen Thorac Cardiovasc Surg 70, 770–778 (2022). https://doi.org/10.1007/s11748-022-01797-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11748-022-01797-4

Keywords

Navigation